Development and Feasibility of a Nurse-led Person-centered Education Program
PsoEd
1 other identifier
interventional
24
1 country
1
Brief Summary
Background Psoriasis is a chronic inflammatory skin disease causing reduced quality of life. Psoriasis patients are often insufficiently informed about their disease with its treatment possibilities leading to non-adherence of treatment resulting in unsatisfactory patient outcomes. We therefore propose to develop an educational intervention for psoriasis patients; evaluate the feasibility of implementing it in a nurse-led psoriasis-outpatient clinic and compare the psoriasis percentage reduction, quality of life, health literacy and patient benefit, between patients receiving this educational intervention and those receiving standard care. Method/Design We first will develop an evidence-based educational intervention in collaboration with an expert panel and second will conduct a quasi experimental feasibility study in a psoriasis outpatient clinic in Western Switzerland. Twenty four eligible patients with psoriasis will receive a multidisciplinary education, for 6 weeks. Data will be analyzed using R conducting linear models allowing us to assess the impact of the intervention on psoriasis reduction and other secondary outcomes of interest, once controlled for reliable socio-economic cofounding factors. Discussion This trial will investigate the feasibility of the elaborated nurse-led education and the planed randomized controlled trial. In this study, we will elaborate and provide an informational brochure with information concerning psoriasis in addition to a nurse-led oral educational program in addition to medical standard care. We expect that this nurse-led person-centered intervention will contribute to enhanced education with a higher functioning, better self-efficacy and improved quality of life, better disease knowledge with a better adherence to the medication protocol. The results will further inform the final design of a subsequent large-scale randomized controlled trial, which will examine the effectiveness of this educational intervention. Additionally, through this study the role of the nursing profession and its research will be strengthened in assuring that the voice of individuals, families and communities are incorporated into design and operations of clinical health systems by eliminating gaps and disparities in health care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 26, 2023
CompletedFirst Posted
Study publicly available on registry
February 6, 2023
CompletedStudy Start
First participant enrolled
October 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedApril 27, 2026
April 1, 2026
9 months
January 26, 2023
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
percentage reduction of psoriasi
percentage reduction of psoriasis using the PASI (Psoriasis Area and Severity Index) score. The intensity of redness, thickness, and scaling of the psoriasis is assessed as none (0), mild (1), moderate (2), severe (3), or very severe (4).
6 weeks
Secondary Outcomes (7)
Health Literacy
6 weeks
Patient benefit
6 weeks
Life Quality Index
6 weeks
Psoriasis severity
6 weeks
Medication knowledge
6 weeks
- +2 more secondary outcomes
Study Arms (1)
nurse-led education
OTHERInterventions
Visiting the medical psoriasis outpatient clinic. Receiving a medical consultation, phototherapy and methotrexate treatment. Psoriasis plaque measurement, psoriasis care and questionnaires will be provided by the institute's nurses. After baseline data collection (T0) and random allocation to the intervention group, this usual care will be enhanced by a multidisciplinary nurse-led educational program
Eligibility Criteria
You may qualify if:
- Diagnosed cutaneous psoriasis, regardless of the stage of the disease and treatment type (systemic and/or topic, and/or puva therapy)
- Age over 18 years
- Proficiency in the French language
You may not qualify if:
- Valid informed consent is not or cannot be given
- Patients unable to follow the 6-session therapeutic education program
- Patients currently engaged in any other therapeutic education program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- School of Health Sciences Genevalead
- University of Lausanne Hospitalscollaborator
- University of Lausannecollaborator
Study Sites (1)
Centre hospitalier universitaire vaudois
Lausanne, Canton of Vaud, 1005, Switzerland
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sebastian E Probst, Prof
University of Applied Sciences and Arts Western Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor of Tissue Viability and Wound Care
Study Record Dates
First Submitted
January 26, 2023
First Posted
February 6, 2023
Study Start
October 15, 2024
Primary Completion
June 28, 2025
Study Completion
September 30, 2025
Last Updated
April 27, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Open data source, Yareta